David A. Green
Director of Finance/CFO en SEASTAR MEDICAL HOLDING CORPORATION .
Fortuna: 552 335 $ al 31/03/2024
Perfil
David A.
Green's current job is Chief Financial Officer at Seastar Medical Holding Corp.
Former jobs include Managing Director-Investment Banking at Duff & Phelps LLC, Chief Financial Officer & Treasurer at SJW Group, Chief Financial Officer, Treasurer & VP at Specialized Health Products International, Inc., Member-Center for Strategic Transactions at Ernst & Young LLP, Chief Financial Officer at Q Therapeutics, Inc., Chief Financial Officer at Catheter Connections, Inc., Chief Accounting Officer at Intarcia Therapeutics, Inc., Chief Financial Officer & Treasurer at San Jose Water Co., Chief Financial Officer & Treasurer at SJW Land Co., Chief Financial Officer & Treasurer at The Texas Water Co., Chief Financial Officer & Treasurer at Texas Water Alliance Ltd., Chief Financial Officer, Secretary & Treasurer at Aytu Biopharma, Inc., and Chief Financial Officer at Aytu Biopharma, Inc.Education history includes an MBA from Rochester Christian University and an undergraduate degree from The State University of New York.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/04/2024 | 752 500 ( 1.16% ) | 552 335 $ | 31/03/2024 |
Cargos activos de David A. Green
| Empresas | Cargo | Inicio |
|---|---|---|
| SEASTAR MEDICAL HOLDING CORPORATION | Director of Finance/CFO | 10/01/2024 |
Antiguos cargos conocidos de David A. Green.
| Empresas | Cargo | Fin |
|---|---|---|
| AYTU BIOPHARMA, INC. | Director of Finance/CFO | 01/05/2022 |
| AYTU BIOPHARMA, INC. | Director of Finance/CFO | 31/03/2021 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Comptroller/Controller/Auditor | 01/02/2017 |
Formación de David A. Green.
| Rochester Christian University | Masters Business Admin |
| The State University of New York | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SJW GROUP | Utilities |
| AYTU BIOPHARMA, INC. | Health Technology |
| Empresas privadas | 9 |
|---|---|
Specialized Health Products International, Inc.
 Specialized Health Products International, Inc. Medical SpecialtiesHealth Technology Specialized Health Products International, Inc. develops, manufactures, and markets proprietary disposable medical devices for clinician and patient safety. Its products include LiftLoc, PowerLoc, and MiniLoc Safety Infusion Set, SecureLoc Safety Introducer Needle, SafeStep Huber Needle Set, and Monoject Bone Marrow Biospy Needles. The company was founded in 1993 and is headquartered in Bountiful, UT. | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
San Jose Water Co.
 San Jose Water Co. Water UtilitiesUtilities San Jose Water Co. provides water utility services. It also provides water audits and conservation devices such as low-flow showerheads and faucet aerators. The company was founded in 1866 and is headquartered in San Jose, CA. | Utilities |
SJW Land Co.
 SJW Land Co. Real Estate DevelopmentFinance SJW Land Co. engages in the real estate development. It owns commercial buildings, undeveloped land, and a majority interest in a real estate partnership. The company was founded in 1985 and is headquartered in San Jose, CA. | Finance |
Texas Water Alliance Ltd.
 Texas Water Alliance Ltd. Water UtilitiesUtilities Texas Water Alliance Ltd. supplies and distributes water. The company is headquartered in Dallas, TX. | Utilities |
Duff & Phelps LLC
 Duff & Phelps LLC Investment ManagersFinance Duff & Phelps LLC provides financial advising and investment banking services. It's consulting and investment banking services include financial reporting and tax valuation, fixed asset and real estate consulting, M&A advisory, fairness and solvency opinions, ESOP and ERISA advisory services, legal business solutions and dispute consulting. The company was founded in 1932 and is headquartered in Chicago, IL. | Finance |
The Texas Water Co.
 The Texas Water Co. Water UtilitiesUtilities The Texas Water Co. engages in the supply of water services. Its service area surrounds Canyon Lake and includes approximately 250 square miles within Comal County and southern Blanco County. The company was founded in 1994 and is headquartered in New Braunfels, TX. | Utilities |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Health Technology |
| Seastar Medical Holding Corp. |
- Bolsa de valores
- Insiders
- David A. Green
